Barouch Lab (@BarouchLab) - Twitter-Profil | Zamantika Mersobahis Locabet

Angehefteter Tweet

Barouch Lab@BarouchLab·5 Eyl

New data from the Barouch Lab on BA.2.86. 1. NAb responses to BA.2.86 were lower than to BA.2 but were comparable or higher than to current circulating variants. 2. NAb titers to all variants including BA.2.86 increased following XBB infection

English

22

108

346

864.5K

Barouch Lab retweetet

Waggoner Lab@LabWaggoner·13 Ara

Long COVID involves activation of proinflammatory and immune exhaustion pathways @NatImmunol @BarouchLab nature.com/articles/s4159…

English

0

3

15

1.8K

Barouch Lab retweetet

Science Translational Medicine@ScienceTM·1 Kas

Vaccines for #H5N1 based on either mRNA or an adenovirus vector can shield macaques from the virus when delivered via an intramuscular prime and a mucosal boost regimen, according to new experiments. @lasradoN @BarouchLab @BIDMC_CVVRTrial scim.ag/3KUJqll

Science Translational Medicine tweet media

English

0

2

15

1.8K

Barouch Lab retweetet

Science Translational Medicine@ScienceTM·17 Eki

Vaccines for #H5N1 based on either mRNA or an adenovirus vector can shield macaques from the virus when delivered via an intramuscular prime and a mucosal boost regimen, according to new experiments. @lasradoN @BarouchLab @BIDMC_CVVRTrial scim.ag/3KUJqll

English

1

3

11

1.1K

Barouch Lab retweetet

Ninaad Lasrado, PhD@lasradoN·17 Eki

Excited to share our work on mucosal vaccines against HPAI #H5N1 @ScienceTM @BarouchLab!! We show how mRNA and adenovirus vaccines provide protection against H5N1, with mucosal adenovirus delivery providing near complete protection! science.org/doi/10.1126/sc…

English

0

1

4

221

Barouch Lab retweetet

International Long Covid Awareness@LCawarenessInt·15 Eki

Was informed @BarouchLab is still actively recruiting participants in the New England area-- #LongCovid *Not to be used as medical advice or diagnosis. ILCA does not endorse any trial or sponsor.

Barouch Lab@BarouchLab

Long COVID or PASC may be characterized by persistent activation of chronic inflammatory pathways, affecting millions of Americans. Our latest clinical trial focuses on repurposing Abrocitinib to reduce symptoms in people with Long COVID. Our trial is currently recruiting! (1/2)

English

0

2

1

387

Barouch Lab retweetet

Waggoner Lab@LabWaggoner·15 Eki

Mucosal delivery of a rhesus adenovirus–vectored H5N1 influenza vaccine confers protection against lethal challenge in cynomolgus macaques science.org/doi/10.1126/sc… @ScienceTM @lasradoN @BarouchLab @harvardmed 🇺🇸

English

0

2

7

817

Barouch Lab@BarouchLab·28 Mar

Long COVID or PASC may be characterized by persistent activation of chronic inflammatory pathways, affecting millions of Americans. Our latest clinical trial focuses on repurposing Abrocitinib to reduce symptoms in people with Long COVID. Our trial is currently recruiting! (1/2)

English

3

17

26

8.7K

Barouch Lab retweetet

BIDMC Research@BIDMC_Research·15 Eyl

Published today in @CellCellPress: A new mRNA #TB vaccine developed at @BIDMChealth’s CVVR by @BarouchLab protected mice better than the century-old BCG shot — reducing infection, slowing spread & lowering lung bacterial levels. 🧬💉 dlvr.it/TN5Lmp

English

1

2

152

Barouch Lab retweetet

Waggoner Lab@LabWaggoner·15 Eyl

Mining the CD4 antigen repertoire for next-generation tuberculosis vaccines @BarouchLab @CellCellPress @BIDMChealth @harvardmed 🇺🇸 cell.com/cell/fulltext/…

English

0

1

3

665

Barouch Lab retweetet

Dr. Angela Rasmussen@angie_rasmussen·20 Ağu

Beautiful paper from @BarouchLab looking at H5N1 pathogenesis in rhesus & cynomolgus macaques (link in replies). Dan presented some of this work in Feb at a meeting at Scripps & the mortality data was striking. H5N1 is really pathogenic in macaques, but in species-specific ways.

English

1

7

20

3.7K

Barouch Lab retweetet

Waggoner Lab@LabWaggoner·9 Tem

Mucosal delivery and gene-based vaccines can both enhance boost responses for influenza vaccination in cynomolgus macaques over available vaccines science.org/doi/10.1126/sc… @ScienceTM @BarouchLab

English

0

1

8

872

Barouch Lab retweetet

Science Translational Medicine@ScienceTM·11 Tem

mRNA or adenovirus flu vaccine boosters produce strong immune responses against H1N1 and match the efficacy of a live-attenuated booster in macaques, supporting their potential as a more flexible platform for #influenza vaccines. @BarouchLab @BIDMChealth scim.ag/45Zjb5M

English

0

2

8

1.2K

Barouch Lab retweetet

Ninaad Lasrado, PhD@lasradoN·28 Mar

#LongCovid has impaired millions of people, with no cure on the horizon. @BIDMC_CVVRTrial has launched a trial to test Abrocitinib to alleviate LC symptoms. If you’re around Boston, see if you qualify! 👇@thephysicsgirl @ImmunoFever @EricTopol @VirusesImmunity @LCCampaign

Barouch Lab@BarouchLab

Long COVID or PASC may be characterized by persistent activation of chronic inflammatory pathways, affecting millions of Americans. Our latest clinical trial focuses on repurposing Abrocitinib to reduce symptoms in people with Long COVID. Our trial is currently recruiting! (1/2)

English

1

8

15

1.6K

Barouch Lab@BarouchLab·28 Mar

Email BIDMC-CVVRTRIALS@bidmc.harvard.edu or call 617-735-4610 to inquire. Additional information can also be found here [clinicaltrials.gov/study/NCT06597…]. (2/2)

English

0

5

3

395

Barouch Lab retweetet

Annika Rössler, PhD@AnnikaRoessler·7 Oca

I'm very excited to share our recent paper describing the antigenic relationship of SARS-CoV-2 variants in Nonhuman primates for the first time. @BarouchLab @annetzl @lasradoN @JanineKimpel @Cambridge_Uni @MedUniInnsbruck cell.com/cell-reports/f…

English

1

3

8

466

Barouch Lab retweetet

Ninaad Lasrado, PhD@lasradoN·25 Eki

It took some time for this to come out, but I am glad it's out now @ScienceTM!!! It was a huge effort by our team @BarouchLab @airisyc @CamilleRMazurek and many more to evaluate mucosal immune responses, 4 years into the COVID-19 pandemic. science.org/doi/10.1126/sc…

English

3

8

26

4.6K

Barouch Lab retweetet

JAMA@JAMA_current·3 Eki

This study shows that mpox antibody responses generated by the MVA-BN vaccine wane significantly within 6 to 12 months, potentially leaving individuals vulnerable to reinfection. ja.ma/47UtpTG

English

0

5

7

12.2K

Barouch Lab retweetet

BIDMC Research@BIDMC_Research·3 Eki

New data from @BIDMChealth @BarouchLab suggests that protective immunity against #Mpox may have waned in previously vaccinated individuals and that boosting may be required to maintain robust protection

JAMA@JAMA_current

This study shows that mpox antibody responses generated by the MVA-BN vaccine wane significantly within 6 to 12 months, potentially leaving individuals vulnerable to reinfection. ja.ma/47UtpTG

English

0

3

4

840

Barouch Lab retweetet

Journal of the IAS@jiasociety·17 May

Ahead of #HIVVaccineAwarenessDay JIAS has published a new viewpoint, “The potential of broadly neutralizing antibodies for HIV prevention”. Read it here: bit.ly/4bHHTHj #HVAD @huubgelderblom @BarouchLab

English

0

5

13

1K

Barouch Lab

Entdecken